Published in J Biol Chem on November 08, 2013
Human gene copy number variation and infectious disease. Hum Genet (2014) 0.97
Network-based gene prediction for Plasmodium falciparum malaria towards genetics-based drug discovery. BMC Genomics (2015) 0.91
The Plasmodium falciparum blood stages acquire factor H family proteins to evade destruction by human complement. Cell Microbiol (2015) 0.88
The apicomplexan glideosome and adhesins - Structures and function. J Struct Biol (2015) 0.84
Host-parasite interactions that guide red blood cell invasion by malaria parasites. Curr Opin Hematol (2015) 0.82
Protection of host cells by complement regulators. Immunol Rev (2016) 0.79
Regulators of complement activity mediate inhibitory mechanisms through a common C3b-binding mode. EMBO J (2016) 0.79
Identification of a reticulocyte-specific binding domain of Plasmodium vivax reticulocyte-binding protein 1 that is homologous to the PfRh4 erythrocyte-binding domain. Sci Rep (2016) 0.77
Red cell receptors as access points for malaria infection. Curr Opin Hematol (2016) 0.76
Red blood cell complement receptor one level varies with Knops blood group, α(+)thalassaemia and age among Kenyan children. Genes Immun (2016) 0.75
Role of complement receptor 1 (CR1; CD35) on epithelial cells: A model for understanding complement-mediated damage in the kidney. Mol Immunol (2015) 0.75
Characterization of Inhibitors and Monoclonal Antibodies That Modulate the Interaction between Plasmodium falciparum Adhesin PfRh4 with Its Erythrocyte Receptor Complement Receptor 1. J Biol Chem (2015) 0.75
The Xplor-NIH NMR molecular structure determination package. J Magn Reson (2003) 16.23
Knowledge-based protein secondary structure assignment. Proteins (1995) 14.08
The CCPN data model for NMR spectroscopy: development of a software pipeline. Proteins (2005) 13.03
Modeller: generation and refinement of homology-based protein structure models. Methods Enzymol (2003) 7.15
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. N Engl J Med (2012) 6.64
Invasion of red blood cells by malaria parasites. Cell (2006) 5.94
Receptor and ligand domains for invasion of erythrocytes by Plasmodium falciparum. Science (1994) 5.81
How malaria has affected the human genome and what human genetics can teach us about malaria. Am J Hum Genet (2005) 5.79
A family of erythrocyte binding proteins of malaria parasites. Proc Natl Acad Sci U S A (1992) 5.40
A research agenda to underpin malaria eradication. PLoS Med (2011) 5.34
Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane. Proc Natl Acad Sci U S A (1979) 5.08
Invasion of erythrocytes by malaria merozoites. Science (1975) 4.54
Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum. Nature (2011) 3.83
Immunological processes in malaria pathogenesis. Nat Rev Immunol (2005) 3.80
Plasmodium falciparum erythrocyte invasion through glycophorin C and selection for Gerbich negativity in human populations. Nat Med (2002) 3.29
Molecular mechanism for switching of P. falciparum invasion pathways into human erythrocytes. Science (2005) 2.81
Super-resolution dissection of coordinated events during malaria parasite invasion of the human erythrocyte. Cell Host Microbe (2011) 2.37
Erythrocyte-binding antigen 175 mediates invasion in Plasmodium falciparum utilizing sialic acid-dependent and -independent pathways. Proc Natl Acad Sci U S A (2003) 2.31
Human C3b/C4b receptor (CR1). Demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristics of C3/C4 binding proteins. J Exp Med (1987) 2.28
Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure. N Engl J Med (2013) 2.24
A Plasmodium falciparum homologue of Plasmodium vivax reticulocyte binding protein (PvRBP1) defines a trypsin-resistant erythrocyte invasion pathway. J Exp Med (2001) 2.22
Human genes for three complement components that regulate the activation of C3 are tightly linked. J Exp Med (1985) 2.12
Identification of an additional class of C3-binding membrane proteins of human peripheral blood leukocytes and cell lines. Proc Natl Acad Sci U S A (1985) 2.11
Complement receptor 1 is the host erythrocyte receptor for Plasmodium falciparum PfRh4 invasion ligand. Proc Natl Acad Sci U S A (2010) 1.91
Invasion by P. falciparum merozoites suggests a hierarchy of molecular interactions. PLoS Pathog (2005) 1.82
Morphology and kinetics of the three distinct phases of red blood cell invasion by Plasmodium falciparum merozoites. Int J Parasitol (2008) 1.70
Solution structure of a pair of complement modules by nuclear magnetic resonance. J Mol Biol (1993) 1.68
Structure and flexibility of the multiple domain proteins that regulate complement activation. Immunol Rev (2001) 1.67
Complement receptor 1 is a sialic acid-independent erythrocyte receptor of Plasmodium falciparum. PLoS Pathog (2010) 1.65
Glycophorin B is the erythrocyte receptor of Plasmodium falciparum erythrocyte-binding ligand, EBL-1. Proc Natl Acad Sci U S A (2009) 1.60
Complement Receptor 1: disease associations and therapeutic implications. Mol Immunol (2008) 1.48
Erythrocyte and reticulocyte binding-like proteins of Plasmodium falciparum. Trends Parasitol (2011) 1.47
Structure-function relationships of complement receptor type 1. Immunol Rev (2001) 1.47
Sites within the complement C3b/C4b receptor important for the specificity of ligand binding. Proc Natl Acad Sci U S A (1991) 1.34
EBL-1, a putative erythrocyte binding protein of Plasmodium falciparum, maps within a favored linkage group in two genetic crosses. Mol Biochem Parasitol (2000) 1.31
Antibodies to reticulocyte binding protein-like homologue 4 inhibit invasion of Plasmodium falciparum into human erythrocytes. Infect Immun (2009) 1.29
Structure of the C3b binding site of CR1 (CD35), the immune adherence receptor. Cell (2002) 1.25
Organization of the genes encoding complement receptors type 1 and 2, decay-accelerating factor, and C4-binding protein in the RCA locus on human chromosome 1. J Exp Med (1988) 1.25
Analysis of the functional domains of complement receptor type 1 (C3b/C4b receptor; CD35) by substitution mutagenesis. J Biol Chem (1994) 1.24
Decay accelerating activity of complement receptor type 1 (CD35). Two active sites are required for dissociating C5 convertases. J Biol Chem (1999) 1.22
Identification of an alternative polyadenylation site in the human C3b/C4b receptor (complement receptor type 1) transcriptional unit and prediction of a secreted form of complement receptor type 1. J Exp Med (1988) 1.16
International Society of Blood Transfusion Committee on terminology for red cell surface antigens: Vancouver Report. Vox Sang (2003) 1.16
Structure of the N-terminal region of complement factor H and conformational implications of disease-linked sequence variations. J Biol Chem (2008) 1.16
Population genetics of GYPB and association study between GYPB*S/s polymorphism and susceptibility to P. falciparum infection in the Brazilian Amazon. PLoS One (2011) 1.13
Structure-function analysis of the active sites of complement receptor type 1. J Biol Chem (1998) 1.09
Reticulocyte binding protein homologues are key adhesins during erythrocyte invasion by Plasmodium falciparum. Cell Microbiol (2009) 1.08
Analysis of the human regulators of complement activation (RCA) gene cluster with yeast artificial chromosomes (YACs). Genomics (1992) 1.06
Glycophorin C (Gerbich antigen blood group) and band 3 polymorphisms in two malaria holoendemic regions of Papua New Guinea. Am J Hematol (2004) 1.03
Plasmodium falciparum uses a key functional site in complement receptor type-1 for invasion of human erythrocytes. Blood (2011) 1.02
Effects of natural selection and gene conversion on the evolution of human glycophorins coding for MNS blood polymorphisms in malaria-endemic African populations. Am J Hum Genet (2011) 1.00
Evidence for linkage between the loci coding for the binding protein for the fourth component of human complement (C4BP) and for the C3b/C4b receptor. Proc Natl Acad Sci U S A (1984) 0.99
Human complement receptor type 1 (CR1) binds to a major malarial adhesin. Trends Mol Med (2002) 0.98
Cell surface expression of the C3b/C4b receptor (CR1) protects Chinese hamster ovary cells from lysis by human complement. J Biol Chem (1992) 0.97
The central portion of factor H (modules 10-15) is compact and contains a structurally deviant CCP module. J Mol Biol (2009) 0.96
Erythrocyte polymorphisms and malaria parasite invasion in Papua New Guinea. Trends Parasitol (2003) 0.89
Reference typing report for complement receptor 1 (CR1). Exp Clin Immunogenet (1998) 0.87
Lack of evidence from studies of soluble protein fragments that Knops blood group polymorphisms in complement receptor-type 1 are driven by malaria. PLoS One (2012) 0.86
Solution structure of CCP modules 10-12 illuminates functional architecture of the complement regulator, factor H. J Mol Biol (2012) 0.86
Duplication and divergence of the amino-terminal coding region of the complement receptor 1 (CR1) gene. An example of concerted (horizontal) evolution within a gene. J Biol Chem (1990) 0.81
Substitution of two amino acids confers C3b binding to the C4b binding site of CR1 (CD35). Analysis based on ligand binding by chimpanzee erythrocyte complement receptor. J Immunol (1996) 0.79
1H, 15N and 13C resonance assignments of complement control protein module pair 2-3 from the C4b-binding site of complement receptor type 1. J Biomol NMR (2004) 0.76
Targeting malaria virulence and remodeling proteins to the host erythrocyte. Science (2004) 7.01
Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood (2006) 4.51
Heterochromatin silencing and locus repositioning linked to regulation of virulence genes in Plasmodium falciparum. Cell (2005) 4.33
Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity (2004) 4.11
Exported proteins required for virulence and rigidity of Plasmodium falciparum-infected human erythrocytes. Cell (2008) 3.80
Lineage-specific expansion of proteins exported to erythrocytes in malaria parasites. Genome Biol (2006) 3.45
Plasmodium falciparum erythrocyte invasion through glycophorin C and selection for Gerbich negativity in human populations. Nat Med (2002) 3.29
Localization of organellar proteins in Plasmodium falciparum using a novel set of transfection vectors and a new immunofluorescence fixation method. Mol Biochem Parasitol (2004) 3.13
Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome. Blood (2008) 3.10
Dissecting apicoplast targeting in the malaria parasite Plasmodium falciparum. Science (2003) 3.08
New approaches to the treatment of dense deposit disease. J Am Soc Nephrol (2007) 3.02
A var gene promoter controls allelic exclusion of virulence genes in Plasmodium falciparum malaria. Nature (2005) 2.99
Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome. J Am Soc Nephrol (2006) 2.88
Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature (2003) 2.83
Molecular mechanism for switching of P. falciparum invasion pathways into human erythrocytes. Science (2005) 2.81
A newly discovered protein export machine in malaria parasites. Nature (2009) 2.79
Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome. Proc Natl Acad Sci U S A (2003) 2.79
Cell-cell communication between malaria-infected red blood cells via exosome-like vesicles. Cell (2013) 2.76
Contribution of the pfmdr1 gene to antimalarial drug-resistance. Acta Trop (2005) 2.72
Negative selection of Plasmodium falciparum reveals targeted gene deletion by double crossover recombination. Int J Parasitol (2002) 2.70
Malaria parasite proteins that remodel the host erythrocyte. Nat Rev Microbiol (2009) 2.62
A genome-wide screen identifies genes required for centromeric cohesion. Science (2004) 2.60
Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells. Blood (2004) 2.58
Phenotypic variation of Plasmodium falciparum merozoite proteins directs receptor targeting for invasion of human erythrocytes. EMBO J (2003) 2.56
Adenovirus type 11 uses CD46 as a cellular receptor. J Virol (2003) 2.52
A conserved molecular motor drives cell invasion and gliding motility across malaria life cycle stages and other apicomplexan parasites. J Biol Chem (2005) 2.50
Type II fatty acid synthesis is essential only for malaria parasite late liver stage development. Cell Microbiol (2008) 2.49
Super-resolution dissection of coordinated events during malaria parasite invasion of the human erythrocyte. Cell Host Microbe (2011) 2.37
Virulence differences between monkeypox virus isolates from West Africa and the Congo basin. Virology (2005) 2.36
C-terminal truncations in human 3'-5' DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy. Nat Genet (2007) 2.35
Structural basis for engagement by complement factor H of C3b on a self surface. Nat Struct Mol Biol (2011) 2.32
Erythrocyte-binding antigen 175 mediates invasion in Plasmodium falciparum utilizing sialic acid-dependent and -independent pathways. Proc Natl Acad Sci U S A (2003) 2.31
T-cell regulation: with complements from innate immunity. Nat Rev Immunol (2006) 2.27
Independent translocation of two micronemal proteins in developing Plasmodium falciparum merozoites. Infect Immun (2002) 2.26
Allelic polymorphisms in apical membrane antigen-1 are responsible for evasion of antibody-mediated inhibition in Plasmodium falciparum. Mol Microbiol (2004) 2.24
That was then but this is now: malaria research in the time of an eradication agenda. Science (2010) 2.23
Reticulocyte-binding protein homologue 5 - an essential adhesin involved in invasion of human erythrocytes by Plasmodium falciparum. Int J Parasitol (2008) 2.19
Immunology of age-related macular degeneration. Nat Rev Immunol (2013) 2.14
Transfection of the human malaria parasite Plasmodium falciparum. Methods Mol Biol (2004) 2.10
A novel erythrocyte binding antigen-175 paralogue from Plasmodium falciparum defines a new trypsin-resistant receptor on human erythrocytes. J Biol Chem (2003) 2.08
Structural basis for complement factor H linked age-related macular degeneration. J Exp Med (2007) 2.02
Development of the endoplasmic reticulum, mitochondrion and apicoplast during the asexual life cycle of Plasmodium falciparum. Mol Microbiol (2005) 2.02
Properdin can initiate complement activation by binding specific target surfaces and providing a platform for de novo convertase assembly. J Immunol (2007) 2.00
Reticulocyte-binding protein homologue 1 is required for sialic acid-dependent invasion into human erythrocytes by Plasmodium falciparum. Mol Microbiol (2005) 1.98
The pluripotency rheostat Nanog functions as a dimer. Biochem J (2008) 1.97
Secreted NS1 of dengue virus attaches to the surface of cells via interactions with heparan sulfate and chondroitin sulfate E. PLoS Pathog (2007) 1.97
West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H. Proc Natl Acad Sci U S A (2006) 1.96
Variation in use of erythrocyte invasion pathways by Plasmodium falciparum mediates evasion of human inhibitory antibodies. J Clin Invest (2008) 1.96
Interaction between Plasmodium falciparum apical membrane antigen 1 and the rhoptry neck protein complex defines a key step in the erythrocyte invasion process of malaria parasites. J Biol Chem (2010) 1.95
Contribution of parasite proteins to altered mechanical properties of malaria-infected red blood cells. Blood (2002) 1.93
An aspartyl protease directs malaria effector proteins to the host cell. Nature (2010) 1.92
Complement receptor 1 is the host erythrocyte receptor for Plasmodium falciparum PfRh4 invasion ligand. Proc Natl Acad Sci U S A (2010) 1.91
A new map of glycosaminoglycan and C3b binding sites on factor H. J Immunol (2008) 1.89
Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes. Invest Ophthalmol Vis Sci (2009) 1.86
Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome. Mol Immunol (2006) 1.82
Invasion by P. falciparum merozoites suggests a hierarchy of molecular interactions. PLoS Pathog (2005) 1.82
CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like syndrome, and defective IL-10 expression from CD4 lymphocytes. J Allergy Clin Immunol (2006) 1.81
Negative selection using yeast cytosine deaminase/uracil phosphoribosyl transferase in Plasmodium falciparum for targeted gene deletion by double crossover recombination. Mol Biochem Parasitol (2006) 1.81
Association between naturally acquired antibodies to erythrocyte-binding antigens of Plasmodium falciparum and protection from malaria and high-density parasitemia. Clin Infect Dis (2010) 1.79
Regulation of apicomplexan actin-based motility. Nat Rev Microbiol (2006) 1.78
Rare variants in CFI, C3 and C9 are associated with high risk of advanced age-related macular degeneration. Nat Genet (2013) 1.77
VAR2CSA is the principal ligand for chondroitin sulfate A in two allogeneic isolates of Plasmodium falciparum. Mol Biochem Parasitol (2006) 1.77
Antagonism of the complement component C4 by flavivirus nonstructural protein NS1. J Exp Med (2010) 1.76
Sir2 paralogues cooperate to regulate virulence genes and antigenic variation in Plasmodium falciparum. PLoS Biol (2009) 1.72
Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design. Proc Natl Acad Sci U S A (2009) 1.72
Molecular genetics and comparative genomics reveal RNAi is not functional in malaria parasites. Nucleic Acids Res (2009) 1.71
A subset of Plasmodium falciparum SERA genes are expressed and appear to play an important role in the erythrocytic cycle. J Biol Chem (2002) 1.71
The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome. J Immunol (2009) 1.70
A genetic screen for improved plasmid segregation reveals a role for Rep20 in the interaction of Plasmodium falciparum chromosomes. EMBO J (2002) 1.69
The PHD and chromo domains regulate the ATPase activity of the human chromatin remodeler CHD4. J Mol Biol (2012) 1.69
Moving in and renovating: exporting proteins from Plasmodium into host erythrocytes. Nat Rev Microbiol (2010) 1.69
Identification and prioritization of merozoite antigens as targets of protective human immunity to Plasmodium falciparum malaria for vaccine and biomarker development. J Immunol (2013) 1.68
The FK506 binding protein Fpr3 counteracts protein phosphatase 1 to maintain meiotic recombination checkpoint activity. Cell (2005) 1.68
Plasmodium falciparum heterochromatin protein 1 marks genomic loci linked to phenotypic variation of exported virulence factors. PLoS Pathog (2009) 1.67
Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells. Nat Immunol (2010) 1.67
Role of the Plasmodium export element in trafficking parasite proteins to the infected erythrocyte. Traffic (2008) 1.64
Critical role of the C-terminal domains of factor H in regulating complement activation at cell surfaces. J Immunol (2006) 1.63
Plasmodium falciparum erythrocyte membrane protein-1 specifically suppresses early production of host interferon-gamma. Cell Host Microbe (2007) 1.61
Hepatic IL-17 responses in human and murine primary biliary cirrhosis. J Autoimmun (2008) 1.57
Signal-mediated export of proteins from the malaria parasite to the host erythrocyte. J Cell Biol (2005) 1.57
Trafficking of the major virulence factor to the surface of transfected P. falciparum-infected erythrocytes. Blood (2005) 1.56
Properdin: emerging roles of a pattern-recognition molecule. Annu Rev Immunol (2010) 1.55
Selective inhibition of a two-step egress of malaria parasites from the host erythrocyte. J Biol Chem (2003) 1.54
Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome. Blood (2007) 1.53